The slip
PARKINSON RECEIPTno. 6169
22 Oct 2026, 06:44 UTCdopamine neurons, braak
predictionRUBCN in dopamine neurons tracks Braak Lewy-body stage
registerede8dcea4c6e32f9c8
discovery+0.01 p=0.982 n=9
replication-0.49 p=0.181 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.01, p 0.982)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc5e9f49576a980d898034d03…
follows fbe3fc5246a6…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 6169: RUBCN in dopamine neurons, braak
- power
- full sample -0.20 (p 0.429, n 18), 95% CI -0.61 to +0.30. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.10 (p 0.690, n 18). does not hold up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.00 (p 0.997, n 18). could be the mix.
- skeptic
- leave-one-out range -0.28 to -0.10, sign flips 0; without severely affected donors -0.20 (p 0.429, n 18). fragile.
- cell type
- strongest in OPCs: -0.67 (p 0.0024, n 18) vs -0.20 in dopamine neurons. proposing OPCs.
- axis
- no measure beats "tracks Braak Lewy-body stage" for RUBCN in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up RUBCN · OPCs · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.35 p 0.214 (needs p < 3.2e-4)